Has Cybil Corning, MD received payments from drug or device companies?

Yes. Drug and device makers reported $2,987 in general payments to Cybil Corning, MD across 80 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Cybil Corning, MD did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Cybil Corning, MD come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Cybil Corning, MD

Colon & Rectal Surgery · Tucson, AZNPI 1235337304

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,430 of the $2,987 with a category attached, or 81.4%. 28 manufacturers reported payments, led by Intuitive Surgical at 46.1% of the total. Reporting peaked in 2019 at $937 and has fallen 51.5% since, to $455 in 2025. That places this record below the midpoint for colon & rectal surgery clinicians in AZ, where the typical reported total is $5,787.

$2,987in general payments, 2019–2025

Across 80 payments — averaging $37.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Intuitive Surgical$1K
Amgen$285
Coloplast$264
Incyte Corporation$172
Sobi, Inc$85
Medtronic$81
plus $721 from 22 others

What the payments were for

Consulting fees$512%
Travel & lodging$50517%
Food & beverage$2,43081%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Intuitive Surgical	10	$1,378
Amgen	19	$285
Coloplast	3	$264
Incyte Corporation	8	$172
Sobi, Inc	4	$85
Medtronic	2	$81
Bayer	5	$81
Davol Inc.	2	$63
Myovant Sciences Inc.	3	$55
Vertex	2	$46
Merck	2	$38
Seagen Inc.	2	$38
Pfizer	2	$35
Genentech USA, Inc.	1	$35
Takeda Pharmaceuticals U.S.A., Inc.	2	$33
Pacira Pharmaceuticals Incorporated	1	$32
Blueprint Medicines Corporation	1	$29
Novartis	1	$28
Beone Medicines USA, Inc.	1	$28
Beigene USA, Inc.	1	$28
Sumitomo Pharma America, Inc.	1	$26
Exelixis Inc.	1	$23
Sanofi	1	$22
Biom'up SA	1	$20
Baxter Healthcare	1	$17
Solventum Corporation	1	$16
Lilly USA, LLC	1	$14
Axonics, Inc.	1	$14

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

Da Vinci Surgical System$1,059
SenSura Mio$136

How this compares

$2,987 in reported general payments places this provider in the 30th percentile of 50 colon & rectal surgery providers in Arizona.

See all colon & rectal surgery providers in Arizona →

Medicare billing

Part B allowed, 2024

$102,048

Medicare patients

139

Services billed

340

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates	27	$1,725
Enoxaparin Sodium	12	$910
Neomycin Sulfate	63	$368
Diphenoxylate-AtropineDiphenoxylate Hcl/Atropine	11	$305
Ondansetron OdtOndansetron	54	$196
Metronidazole	65	$116
Oxycodone Hcl	21	$51

Paid to pharmacies, not to this prescriber.

Other colon & rectal surgery in Tucson

Philip RosenTucson$17K
Stefanie SchluenderTucson$6K
Jessica StephensTucson$5K
Susan ParkerTucson$20
James KleinTucson$18
Deborah KellerScottsdale$195K
Eugene KimPhoenix$189K
Sushil PandeySurprise$125K
Hekmat HakimanChandler$57K
Ashley CasanoPhoenix$48K

See the full list for Arizona →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →